CereVasc, Inc., a clinical-stage medical device company developing minimally invasive treatments for neurological diseases, announced the opening of its new manufacturing and research facility in Wilmington, Massachusetts, following two major milestones: completion of enrollment in its STRIDE pivotal trial and the cl…
Octapharma, the largest privately owned and independent plasma fractionator in the world, has formally announced plans to establish its first-ever United States-based manufacturing and production site at the Palmetto Research Park in Rock Hill, South Carolina. The $1.5 billion project is expected to bring 1,500 full-t…
GSK plc announced plans to establish a major new global R&D centre in Cambridge, UK, as part of the company’s plan to accelerate its R&D pipeline. The new 300,000 square foot site, on the Cambridge Biomedical Campus in the heart of the UK’s life sciences “Golden Triangle,” will be home to GSK’s R&D operati…
AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group announced that construction of its new R&D building has officially broken ground at the Shanghai Fengxian site. The project marks a pivotal infrastructure step in strengthening AsymBio's biolo…
Telix Pharmaceuticals Limited officially opens a multi-million dollar radiopharmaceutical research, manufacturing and treatment facility in Melbourne, expanding and strengthening Australia's capability in one of the world's fastest-growing areas of cancer diagnosis and treatment. Telix Manufacturing Solutions North…
Medline has announced plans to open a new distribution center in Perris, Calif. The approximately 1 million-square-foot facility represents another company investment in its California and overall distribution network, adding capacity and operational flexibility to support healthcare providers across the state. "This…
Alliance for Building Better Medicine, the coalition leading Virginia's Advanced Pharmaceutical Manufacturing (APM) Tech Hub, announced a $15.97 million investment from the U.S. Economic Development Administration (EDA) to launch the End-to-End (E2E) Commercialization Project. The initiative will help establish a dome…
Bristol Myers Squibb, a global biopharmaceutical leader, announced it will expand its compute infrastructure to deploy an NVIDIA DGX SuperPOD with DGX Vera Rubin NVL72 systems, giving BMS the most powerful and energy-efficient single-owned NVIDIA infrastructure in life sciences. The expanded Vera Rubin infrastructure…
Bora Biologics, a U.S.-based biologics CDMO engineered for licensed supply, announced the expansion of its U.S. drug substance manufacturing platform through the addition of the Rockville, Maryland site. The addition strengthens the company’s U.S.-anchored BioSecure commercial platform and reinforces its long-term inv…
Pierre Guérin has established itself as a key player of equipment design, manufacturing, installation, and maintenance services for process industries such as pharmaceuticals and biotechnology. Its mission is to support its clients in high-value-added process industries in achieving operational excellence and sustaina…
Page 2 of 58